RENAL SAFETY OF TENOFOVIR DISOPROXIL FUMARATE AND ENTECAVIR WITH HEPATITIS B IMMUNOGLOBULIN IN LIVER TRANSPLANT PATIENTS

被引：0
|
作者：
Lee, Juhan [1 ]
Park, Jun Yong [2 ]
Yang, Seok Jeong [1 ]
Lee, Jee Youn [3 ]
Kim, Deok Gie [4 ]
Joo, Dong Jin [1 ]
Kim, Myoung Soo [1 ]
Kim, Soon Il [1 ]
Lee, Jae Geun [1 ]
机构：
[1] Yonsei Univ, Surg, Coll Med, Seoul, South Korea
[2] Yonsei Univ, Internal Med, Coll Med, Seoul, South Korea
[3] Gangbuk Samsung Med Ctr, Surg, Seoul, South Korea
[4] Wonju Severance Christian Hosp, Surg, Wonju, South Korea
来源：
TRANSPLANTATION | 2020年 / 104卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P-12.106
引用
收藏
页码：S540 / S540
页数：1
相关论文
共 50 条
  • [41] Entecavir versus tenofovir disoproxil fumarate on the reduction of incidence of hepatocellular carcinoma in patients with chronic hepatitis B-related liver cirrhosis
    Lin, Yu-Hung
    Lai, Huang-Lun
    Wang, Chun-Hsiang
    Chang, Kuo-Kuan
    Mo, Lein-Ray
    Lin, Ruey-Chang
    ADVANCES IN DIGESTIVE MEDICINE, 2024, 11 (01) : 16 - 23
  • [42] Effects of entecavir and tenofovir disoproxil fumarate on the incidence and severity of COVID-19 in patients with chronic hepatitis B
    Xingmei Liao
    Yujie Fan
    Chunxiu Zhong
    Siru Zhao
    Liangxu Guo
    Wenjuan Tan
    Junhua Yin
    Rong Fan
    BMC Infectious Diseases, 23
  • [43] Hepatocellular carcinoma and death and transplantation in chronic hepatitis B treated with entecavir or tenofovir disoproxil fumarate
    Ha, Yeonjung
    Chon, Young Eun
    Kim, Mi Na
    Lee, Joo Ho
    Hwang, Seong Gyu
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [44] Tenofovir disoproxil fumarate is not associated with a lower risk of hepatocellular carcinoma compared to entecavir in patients with chronic hepatitis B
    Lee, Hye Won
    Kim, Seung Up
    HEPATOMA RESEARCH, 2022, 8
  • [45] Virologic breakthrough in a patient with chronic hepatitis B by combination treatment with tenofovir disoproxil fumarate and entecavir
    Suzuki, Fumitaka
    Sezaki, Hitomi
    Akuta, Norio
    Suzuki, Yoshiyuki
    Kawamura, Yusuke
    Hosaka, Tetsuya
    Kobayashi, Masahiro
    Saitoh, Satoshi
    Arase, Yasuji
    Ikeda, Kenji
    Kobayashi, Mariko
    Watahiki, Sachiyo
    Mineta, Rie
    Suzuki, Yukiko
    Kumada, Hiromitsu
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2014, 8 : 869 - 873
  • [46] Effects of entecavir and tenofovir disoproxil fumarate on the incidence and severity of COVID-19 in patients with chronic hepatitis B
    Liao, Xingmei
    Fan, Yujie
    Zhong, Chunxiu
    Zhao, Siru
    Guo, Liangxu
    Tan, Wenjuan
    Yin, Junhua
    Fan, Rong
    BMC INFECTIOUS DISEASES, 2023, 23 (01)
  • [47] Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B
    Hsu, Yao-Chun
    Yeh, Ming-Lun
    Wong, Grace Lai-Hung
    Chen, Chien-Hung
    Peng, Cheng-Yuan
    Buti, Maria
    Enomoto, Masaru
    Xie, Qing
    Trinh, Huy
    Preda, Carmen
    Liu, Li
    Cheung, Ka-Shing
    Yeo, Yee Hui
    Hoang, Joseph
    Huang, Chung-Feng
    Riveiro-Barciela, Mar
    Kozuka, Ritsuzo
    Istratescu, Doina
    Tsai, Pei-Chien
    Accarino, Elena Vargas
    Lee, Dong-Hyun
    Wu, Jia-Ling
    Huang, Jee Fu
    Dai, Chia-Yen
    Cheung, Ramsey
    Chuang, Wan-Long
    Yuen, Man-Fung
    Wong, Vincent Wai-Sun
    Yu, Ming-Lung
    Nguyen, Mindie H.
    JOURNAL OF INFECTIOUS DISEASES, 2021, 224 (11): : 1890 - 1899
  • [48] Hepatocellular carcinoma and death and transplantation in chronic hepatitis B treated with entecavir or tenofovir disoproxil fumarate
    Yeonjung Ha
    Young Eun Chon
    Mi Na Kim
    Joo Ho Lee
    Seong Gyu Hwang
    Scientific Reports, 10
  • [49] COMPARATIVE EFFICACY AND RENAL SAFETY OF ENTECAVIR, TENOFOVIR DISOPROXIL FUMARATE AND TENOFOVIR ALAFENAMIDE FOR HBV-INFECTED CANCER PATIENTS UNDERGOING CHEMOTHERAPY
    Lee, I-Cheng
    Lan, Keng-Hsin
    Su, Chien-Wei
    Chao, Yee
    Lin, Han-Chieh
    Hou, Ming-Chih
    Huang, Yi Hsiang
    HEPATOLOGY, 2021, 74 : 473A - 474A
  • [50] SWITCHING FROM TENOFOVIR DISOPROXIL FUMARATE TO TENOFOVIR ALAFENAMIDE: ASSESSING THE CHANGE IN RENAL FUNCTION IN HEPATITIS B PATIENTS
    Lee, Minna
    Lee, Susan M. K.
    Bernstein, David Eric
    HEPATOLOGY, 2019, 70 : 316A - 316A
12345